Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

602 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Completed

Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)

NCT05067478

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • 43rd Medical Associates Phoenix, Arizona, United States
  • Fiel Family and Sports Medicine, PC Tempe, Arizona, United States
  • Arkansas Urology Associates, PA Little Rock, Arkansas, United States
View all 64 locations
View Trial Details
Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

NCT02216214

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Site US00066 Huntsville, Alabama, United States
  • Site US00148 Mobile, Alabama, United States
  • Site US00009 Anchorage, Alaska, United States
  • Site US00020 Tucson, Arizona, United States
View all 120 locations
View Trial Details
Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00912964

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Chandler, Arizona, United States
View all 151 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

NCT01638000

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site: 37406 Yerevan, Armenia
  • Site: 37404 Yerevan, Armenia
  • Site: 37403 Yerevan, Armenia
  • Site: 37401 Yerevan, Armenia
View all 217 locations
View Trial Details
Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00688688

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Montgomery, Alabama, United States
View all 308 locations
View Trial Details
Completed

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00662909

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Montgomery, Alabama, United States
View all 125 locations
View Trial Details

Related conditions